Safety and efficacy of Compound Huangdai Tablets combined with all-trans retinoic acid for treatment of acute promyelocytic leukemia: Clinical evidence and potential mechanisms

OBJECTIVE: To evaluate the safety and efficacy of Compound Huangdai Tablets (Realgar-Indigo Naturalis formula, RIF) combined with all-trans retinoic acid (ATRA) to treat acute promyelocytic leukemia (APL). METHODS: This study was registered in PROSPERO (CRD42018108118). The relevant literatures on R...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Qianqian, Wang, Tao, Xiong, Yan, Qu, Liping, Yin, Qiaozhi, Zou, Wenjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476755/
https://www.ncbi.nlm.nih.gov/pubmed/36120125
http://dx.doi.org/10.1016/j.chmed.2021.09.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476755/
https://www.ncbi.nlm.nih.gov/pubmed/36120125
http://dx.doi.org/10.1016/j.chmed.2021.09.004

Ejemplares similares